| Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer SK Tripathi, K Pandey, KRR Rengasamy, BK Biswal Medicinal research reviews 40 (6), 2132-2176, 2020 | 39 | 2020 |
| Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway K Pandey, SK Tripathi, M Panda, BK Biswal Toxicology in Vitro 65, 104788, 2020 | 20 | 2020 |
| The potential of retinoids for combination therapy of lung cancer: updates and future directions SK Tripathi, K Pandey, M Panda, MJ Spinella, KR Rengasamy, BK Biswal Pharmacological research 147, 104331, 2019 | 18 | 2019 |
| Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy SK Tripathi, K Pandey, M Panda, BK Biswal AGO-Driven Non-Coding RNAs, 293-318, 2019 | 3 | 2019 |
| Augmentation of Plant Salt Stress Tolerance by Microorganisms K Pandey, A Adhikari, V Pant, TS Bisht Microbiological Activity for Soil and Plant Health Management, 237-264, 2021 | | 2021 |
| Biofortification of Plants by Using Microbes A Adhikari, K Pandey, V Pant, TS Bisht, H Punetha Microbial Technology for Sustainable Environment, 141-166, 2021 | | 2021 |
| SOX9 promotes gefitinib resistance in non-small cell lung carcinoma through differential expression of epithelial to mesenchymal transition markers BK Biswal, SK Tripathi, M Panda, K Pandey | | 2019 |
Surya Kant TripathiPostdoctoral Research Associate at University of North Carolina Chapel Hill USAVerified email at email.unc.edu
